v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Distributions in Excess of Accumulated Earnings
Accumulated Other Comprehensive Income (Loss)
Balance beginning (in shares) at Dec. 31, 2024   55,075,006      
Balance beginning at Dec. 31, 2024 $ 1,403,185 $ 551 $ 1,998,777 $ (607,499) $ 11,356
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted common stock and issuance of performance-based deferred stock unit awards (in shares)   118,096      
Stock-based compensation 1,261 $ 1 1,260    
Repurchases of common stock (in shares)   (47,229)      
Repurchases of common stock (1,145) $ (1) (1,144)    
Distributions to common stockholders (22,297)     (22,297)  
Other comprehensive income (loss) (7,138)       (7,138)
Net income 7,898     7,898  
Balance ending (in shares) at Mar. 31, 2025   55,145,873      
Balance ending at Mar. 31, 2025 $ 1,381,764 $ 551 1,998,893 (621,898) 4,218
Balance beginning (in shares) at Dec. 31, 2025 54,876,558 54,876,558      
Balance beginning at Dec. 31, 2025 $ 1,331,298 $ 549 1,994,960 (663,197) (1,014)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted common stock and issuance of performance-based deferred stock unit awards (in shares)   127,503      
Stock-based compensation 1,197 $ 1 1,196    
Repurchases of common stock (in shares)   (49,714)      
Repurchases of common stock (1,196)   (1,196)    
Distributions to common stockholders (22,179)     (22,179)  
Other comprehensive income (loss) 3,039       3,039
Net income $ 12,420     12,420  
Balance ending (in shares) at Mar. 31, 2026 54,954,347 54,954,347      
Balance ending at Mar. 31, 2026 $ 1,324,579 $ 550 $ 1,994,960 $ (672,956) $ 2,025